ArticleCancers2021

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.

Katherine B Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.